tyna moore semaglutide Dr. Using GLP-1s: Benefits, Beyond Obesity

FDA-approved formulations for semaglutide as Ozempic and Wegovy use milligrams and are sold as self-administered injectable pens with a set dosage

Rare but serious cardiovascular adverse effects requiring immediate medical attention include severe chest pain, signs of pancreatitis (which can affect cardiovascular stability), or symptoms suggesting gallbladder disease

Mounjaro is manufactured by the North American pharmaceutical company Eli Lilly, while Wegovy is produced by the Danish company Novo Nordisk

Read more in our editorial policy.

His lawsuit alleges that he was diagnosed with NAION four months later

Rybelsus is the first GLP-1 receptor agonist available in tablet form, offering an alternative to injectable formulations for patients who prefer oral administration